Medical Device Adhesives: UV Cure & Dispensing Validation

Updated2026-08-06

Closed-loop medical device adhesive workflow from device risk and precision dispensing to UV-visible curing and finished-device verification — BIO original evidence map: device and interface inputs flow through dispensing and delivered bond-line cure conditions to joint, sterilization-aging and finished-device biological evaluation. Conceptual; no product ranking. Sources [1–13].

In short: Medical device adhesive selection should work backward from the finished device, body contact, substrate pair, joint geometry, sterilization method and intended life. FDA evaluates the device in its final finished form and does not clear or approve individual fabrication materials.[1] ISO 10993-1:2025 places biological safety inside risk management; FDA recognizes that edition only in part and maintains a transition for the previous edition.[2][3] A defensible program therefore controls material, dispensing, delivered bond-line light, joint performance and finished-device biological evidence instead of treating “ISO 10993 tested” or a seconds-long fixture time as a universal answer.[1][3][7]

Start with the finished device, not a “medical-grade” adhesive

FDA frames biocompatibility around the final finished device and considers material composition, manufacturing methods, sterilization, processing-aid residuals and interactions between components. The agency explicitly states that it does not clear or approve individual materials used to fabricate a device.[1]

ISO 10993-1:2025 places biological-safety evaluation within risk management.[2] FDA granted only partial recognition to that edition and will continue accepting declarations to ISO 10993-1:2018 until July 1, 2029; using the newest edition does not automatically resolve every FDA expectation.[3] Chemical characterization may address substances introduced by manufacturing, sterilization residuals, extractables and leachables, with toxicological risk assessment applied when needed.[4][5]

Select adhesive chemistry and interface before cure mode

UV or visible light describes a cure trigger, not one polymer family. Dymax identifies MD 1-CN006 as an acrylated urethane, while Henkel identifies LOCTITE 4307 as a cyanoacrylate with light cure and a secondary moisture cure. These first-party examples show why two products carrying a light-cure label may differ in chemistry, flexibility, shadow cure and interface behavior.[7][8]

Record exact substrate grades and surface state, bond-line gap, load and flexibility, body contact, sterilization, aging environment, takt time and any shadowed region.[1][7][8]
A supplier endpoint test or “medical grade” description is material information, not a finished-device biological-safety conclusion.[1][4][5]

Qualify UV/visible cure at the actual bond line

A fixture time from one data sheet cannot be copied to a different lamp, substrate or joint. The MD 1-CN006 sheet distinguishes fixture from full cure and says actual cure time is typically three to five times fixture time for that product. It also warns that light-blocking substrates may require longer exposure and recommends determining full cure empirically by tracking properties such as tack, adhesion and hardness until further exposure produces no improvement. Those figures are product- and condition-specific.[7]

Record wavelength range, irradiance at bond-line position, exposure time, distance, bond-line thickness, substrate transmission and light-source condition.[7]
Link release criteria to measurable outputs such as coverage, cure state, joint performance and failure mode, not only programmed exposure time.[6][7]

Define precision dispensing as controlled volume, not the smallest needle

Nordson EFD links deposit size to tip inner diameter, fluid viscosity, the receiving surface and pulse duration. Low-viscosity materials may spread, narrow flow paths may create excessive back pressure for viscous materials, and tip-to-part distance can affect material release.[9]

A progressive-cavity pump may reduce the effect of viscosity variation on delivered volume, but the volume, repeatability and accuracy values on the 797PCP page are manufacturer data for that specified system, not universal performance for every adhesive and setup.[10] Process work should still challenge fluid temperature, residence time, bubbles, pressure or rotation, suck-back, tip lot and restart conditions.[9][10]

Move from screening coupons to representative device joints

ASTM D1002 describes the metal single-lap shear test primarily as a comparative method and warns against treating small-specimen results as design-allowable values for joints with different adherends, geometry or bonding processes. Temperature, moisture and mismatched expansion behavior can also change apparent strength.[11]

Use coupons to compare wetting, cure, strength and failure mode, then move to representative joints made with the intended production process and predetermined acceptance criteria.[6][11]
Boundary studies should consider minimum and maximum deposit, lowest delivered bond-line exposure, largest gap, material and equipment lots, sterilization, aging and service load.[1][6][11]

FDA’s QMSR became effective on February 2, 2026 and incorporates ISO 13485:2016 into the 21 CFR Part 820 framework. Applicable material, equipment, validation, change and production records therefore belong under the manufacturer’s current quality-system controls.[6]

Treat silicone and dissimilar-material bonding as a separate interface problem

NuSil states that silicone primers are used to improve bonding between silicone adhesives and low-surface-energy materials, and lists silicone, metals and several plastics among the relevant substrates. Its primer page also describes these systems as moisture- and time-sensitive and gives a typical 10–15 minute primer cure interval before adhesive application.[12]

NuSil MED1-4213 illustrates a different process route: a two-part, platinum-catalyzed addition-cure adhesive with a typical Part A viscosity of 80,000 cP and stated applications including silicone-to-silicone, metals and urethanes.[13] The same TDS says its data are typical, may not be tested lot by lot and cannot be used directly to draft specifications.[13] Silicone bonding is therefore not merely another entry in a generic “UV glue” list.

Sources and reading boundary

Sources [7–13] are product- or equipment-specific manufacturer materials. They support only the stated application and process points; they are not universal proof for other products and do not establish a finished-device regulatory conclusion.

The BIO angle

For BIO readers working around medical silicone and device manufacturing, the defensible connection is a single requirement sheet that joins exact product documentation, substrate and primer, controlled deposit, delivered bond-line cure, sterilization-aging and finished-device evaluation. This article does not claim that BIO performs testing, process validation or regulatory review, and it does not confirm authorization, inventory or supply status for any product; those points require separate verification.

FAQ

Is an adhesive suitable for a medical device because it was tested to ISO 10993?

Not by that statement alone. The exact endpoint and test-article state must be identified, then considered with the finished device’s contact, duration, manufacturing, sterilization and residuals.[1][2][4][5]

Is UV adhesive fixture time the same as full cure?

Not necessarily. The MD 1-CN006 sheet distinguishes fixture from full cure and calls for empirical qualification under the actual irradiance, substrate and bond-line conditions. Its timing relationship cannot be generalized to other adhesives.[7]

Does precision dispensing simply mean selecting a smaller tip?

No. Tip ID, viscosity, surface, distance and pneumatic or volumetric settings all affect output, while an overly narrow flow path can increase back pressure. Validate delivered amount and variation with the actual fluid.[9][10]

Can a UV/visible-light adhesive be used directly on silicone?

There is no category-wide answer. Teams must evaluate the exact silicone surface, adhesive chemistry, primer or treatment, flexibility, shadowed regions and sterilization conditions in a representative joint.[7][12][13]

How to select and validate medical device adhesives: UV/visible curing and precision dispensing